Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

50.34
Delayed Data
As of 4:02pm ET
 +0.39 / +0.78%
Today’s Change
36.81
Today|||52-Week Range
50.65
+24.48%
Year-to-Date
Alnylam/Sanofi's RNAi Drug Meets Endpoint in Study, Stock Up
Sep 21 / Zacks.com - Paid Partner Content
AstraZeneca's Asthma Candidate Shows Promising Results
Sep 12 / Zacks.com - Paid Partner Content
Is Sanofi (SNY) a Great Stock for Value Investors?
Sep 21 / Zacks.com - Paid Partner Content
AbbVie's Upadacitinib Meets Primary Endpoint in Phase IIb
Sep 08 / Zacks.com - Paid Partner Content
Silverback Asset Management Llc Buys Becton, Dickinson and Co, Sanofi Contingent Valu...
Sep 18 / GuruFocus News - Paid Partner Content
Regeneron's Cemiplimab Gains Breakthrough Therapy Status
Sep 08 / Zacks.com - Paid Partner Content
Biotech Mailbag: Buy Dip in T2 Biosystems?
Sep 15 / TheStreet.com - Paid Partner Content
Alnylam Shares Plunge on Patient Death, Dosing Suspended
Sep 08 / Zacks.com - Paid Partner Content
Lilly/Incyte's Baricitinib Meets Endpoint in Eczema Study
Sep 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close49.95
Today’s open50.52
Day’s range50.15 - 50.65
Volume774,776
Average volume (3 months)1,459,561
Market cap$125.4B
Dividend yield3.26%
Data as of 4:02pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+11.60%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.10%
Revenue growth (last year)-2.08%
P/E ratio27.2
Price/Sales2.81
Price/Book2.06

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.07+0.08%
CELGCelgene+0.11+0.08%
GSKGlaxoSmithKline+0.25+0.62%
BMYBristol-Myers Squibb+0.03+0.05%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.03
Annual revenue (last year)$37.3B
Annual profit (last year)$5.2B
Net profit margin12.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts